Marker
Advanced Targeting Analytics Content Content Discovery Platform Content Generation

Business Overview

Investor type
Venture Capital
Business model preference
B2B, B2G
Series preference
Seed, Series A, Series B, Series C, Series C+, Series D, Series E
Offering preference
Software
AI type preference
Artificial Intelligence, Computer Vision, Deep Learning, Machine Learning, Natural Language Generation, Natural Language Processing
Sectors
Advanced Targeting Analytics Content Content Discovery Platform Content Generation Content Performance Analytics Customer Engagement Customer Interaction Data Analytics Enterprise Marketing Sales Solution

Investment Portfolio

Startup

Operating Status

Offering Type

Business Model

Total Funding

AI Employees

Illusive Networks
Active
Software
B2B
$54 M
Keywee
Active
Software
B2B
$9.1 M
8
Datorama
Acquired
Software
B2B
$50 M
6

Investment Rounds History

Startup

Date Announced

Funding Round

Amount Raised

Investors

October 2020
Series B+
$24 M
View All Investors (8 Total)
November 2017
Series D
$51 M
View All Investors (8 Total)
July 2017
Series C+
$9 M

Similar Investors

Gandyr Group
TYPE
Family Office
MIN CHEQUE
$0.5 M
SBI JI
TYPE
Corporate Venture Capital
TPG Growth
TYPE
Venture Capital
Nielsen Innovate
TYPE
Corporate Venture Capital
MIN CHEQUE
$0.58 M
TAU Ventures
TYPE
Venture Capital
MIN CHEQUE
$0.05 M
Grove Ventures
TYPE
Venture Capital
Foundation Capital
TYPE
Venture Capital
MIN CHEQUE
$6 M
Omron
TYPE
Company
TYPE
Angel
Scale Venture Partners
TYPE
Venture Capital
TransLink Capital
TYPE
Venture Capital
Team8
TYPE
Accelerator
TYPE
Angel
e.ventures
TYPE
Venture Capital
MIN CHEQUE
$0.5 M
TYPE
Angel
Maverick Ventures Israel
TYPE
Venture Capital
MIN CHEQUE
$2 M
Tidhar Construction
TYPE
Company
Samsung
TYPE
Company
Mindset Ventures
TYPE
Venture Capital
MIN CHEQUE
$0.2 M
Tiger Global Management
TYPE
Hedge Fund

Sign up for free

  • Save profiles to your list
  • View all funding rounds
  • Advanced sorting filter access
  • Search investment rounds
  • Search exit events